FP-β-CPPIT: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 26: | Line 26: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:FPCPPIT.svg|FPCPPIT | |||
</gallery> | |||
Latest revision as of 23:57, 24 February 2025
FP-β-CPPIT is a radiopharmaceutical compound used in PET imaging. It is a radioligand for the sigma receptor, specifically the sigma-1 receptor subtype.
Chemistry[edit]
FP-β-CPPIT is a fluorine-18 labeled compound. The fluorine-18 isotope is a positron emitter, which makes it suitable for PET imaging. The compound itself is a derivative of CPPIT, a known sigma-1 receptor ligand.
Use in Imaging[edit]
The primary use of FP-β-CPPIT is in PET imaging of the brain. The sigma-1 receptor is widely distributed in the brain, and its density can be indicative of various neurological and psychiatric conditions. By using FP-β-CPPIT as a radioligand, researchers can visualize the distribution and density of sigma-1 receptors in the brain.
Potential Applications[edit]
Research into the use of FP-β-CPPIT is ongoing. Potential applications include the study of neurodegenerative diseases, psychiatric disorders, and cancer. In neurodegenerative diseases, changes in sigma-1 receptor density may be indicative of disease progression. In psychiatric disorders, alterations in sigma-1 receptor function may be involved in the pathophysiology of the disorder. In cancer, sigma-1 receptors have been found to be overexpressed in certain types of tumors, making them a potential target for imaging and therapy.


